Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection

Infection and Immunity

Volumn 67, Issue 5, 1999, Pages 2414-2420

  Schwerer, Beatrix ^a   Neisser, Andrea ^a   Bernheimer, Hanno ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN STRUCTURE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 0032925517     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.5.2414-2420.1999     Document Type: Article

References (42)

1. Asbury, A. K., and D. R. Cornblath. 1990. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27(Suppl.):S21-S24.
2. Aspinall, G. O., S. Fujimoto, A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62:2122-2125.
3. Aspinall, G. O., A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33:241-249.
4. Bech, E., T. F. Orntoft, L. P. Andersen, P. Skinhoj, and J. Jakobsen. 1997. IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course. J. Neuroimmunol. 72:59-66.
5. Berlit, P., and J. Rakicky. 1992. The Miller Fisher syndrome: review of the literature. J. Clin. Neuro-Ophthalmol. 12:57-63.
6. Blaser, M. J., and D. J. Duncan. 1984. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect. Immun. 44:292-298.
7. Chiba, A., S. Kusunoki, T. Shimizu, and I. Kanazawa. 1992. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31:677-679.
8. Chiba, A., S. Kusunoki, H. Obata, R. Machinami, and I. Kanazawa. 1993. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43:1911-1917.
9. Deisenhammer, F., G. Keir, B. Pfausler, and E. J. Thompson. 1996. Affinity of anti-GM1 antibodies in Guillain-Bané syndrome patients. J. Neuroimmunol. 66:85-93.
10. Dowling, P. C., and S. D. Cook. 1981. Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpesviruses in 41 cases. Ann. Neurol. 9(Suppl.):44-55.
11. Goldschmidt, B., J. Menonna, J. Fortunato, P. Dowling, and S. Cook. 1980. Mycoplasma antibody in Guillain-Barré syndrome and other neurological diseases. Ann. Neurol. 7:108-112.
12. Griffin, J. W., and T. W. H. Ho. 1993. The Guillain-Barré syndrome at 75: the Campylobacter connection. Ann. Neurol. 34:125-127.
13. Hartung, H.-P., K. V. Toyka, and J. W. Griffin. 1998. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy, p. 294-306. In J. Antel, G. Birnbaum, and H.-P. Hartung (ed.), Clinical neuroimmunology. Blackwell Science, Malden, Mass.
14. Hughes, R. A. C. 1990. The Guillain-Barré syndrome. Springer-Verlag London, United Kingdom.
15. Jacobs, B. C., P. A. van Doorn, P. I. M. Schmitz, A. P. Tio-Gillen, P. Herbrink, L. H. Visser, H. Hooijkaas, and F. G. A. van der Meché. 1996. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann. Neurol. 40:181-187.
16. Klaus, G. G. B. 1990. B cell activation: induction of the primary immune response, 21-39. In D. Male (ed.), B-lymphocytes. Oxford University Press, Oxford, United Kingdom.
17. Kuroki, S., T. Saida, M. Nukina, T. Haruta, M. Yoshioka, Y. Kobayashi, and H. Nakanishi. 1993. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann. Neurol. 33:243-247.
18. Marcus, D. M., N. Latov, B. P. Hsi, B. K. Gillard, and participating laboratories. 1989. Measurement and significance of antibodies against GM1 ganglioside. J. Neuroimmunol. 25:255-259.
19. Mizoguchi, K., A. Hase, T. Obi, H. Matsuoka, M. Takatsu, Y. Nishimura, F. Irie, Y. Seyama, and Y. Hirabayashi. 1994. Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 57:1121-1123.
20. Neisser, A., H. Bernheimer, T. Berger, A. P. Moran, and B. Schwerer. 1997. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect. Immun. 65:4038-4042.
21. Ogino, M., E. Nobile-Orazio, and N. Latov. 1995. IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses. J. Neuroimmunol. 58:77-80.
22. O'Leary, C. P., J. Veitch, W. F. Durward, A. M. Thomas, J. H. Rees, and H. J. Willison. 1996. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J. Neurol. Neurosurg. Psychiatry 61:649-651.
23. Rees, J.H., N. A. Gregson, and R. A.C. Hughes. 1995. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38:809-816.
24. Rees, J. H., S. E. Soudain, N. A. Gregson, and R. A. C. Hughes. 1995. Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333:1374-1379.
25. Ropper, A. H., E. F. M. Wijdicks, and B. T. Truax. 1991. Guillain-Barré syndrome, p. 18-21. F. A. Davis Co., Philadelphia, Pa.
26. Salloway, S., L. A. Mermel, M. Seamans, G. O. Aspinall, J. E. Nam Shin, L. A. Kurjanczyk, and J. L. Penner. 1996. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infect. Immun. 64:2945-2949.
27. Schwartz, M., B. A. Sela, and N. Eshhar. 1982. Antibodies to gangliosides and myelin autoantigens are produced in mice following sciatic nerve injury. J. Neurochem. 38:1192-1195.
28. Schwerer, B., H. Lassmann, K. Kitz, and H. Bernheimer. 1986. Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol. (Berlin) 72:55-61.
29. Schwerer, B., A. Neisser, R. J. Polt, H. Bernheimer, and A. P. Moran, 1995. Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome. J. Endotoxin Res. 2:395-403.
30. van den Berg, L. H., J. Marrink, A. E. J. de Jager, H. J. de Jong, G. W. van Imhoff, N. Latov, and S. A. Sadiq. 1992. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 55:8-11.
31. von Wulfen, H., C. Hartard, and E. Scharein. 1994. Seroreactivity to Campylobacler jejuni and gangliosides in patients with Guillain-Barré syndrome. J. Infect. Dis. 170:828-833.
32. Willison, H. J., and P. G. E. Kennedy. 1993. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J. Neuroimmunol. 46:105-112.
33. Willison, H. J., J. Veitch, G. Palerson, and P. G. E. Kennedy. 1993. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry 56:204-206.
34. Willison, H. J. 1994. Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? J. Neurol. Neurosurg. Psychiatry 57:1303-1307.
35. Willison, H. J., A. Almemar, J. Veitch, and D. Thrush. 1994. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology 44:2395-2397.
36. Willison, H. J., and J. Veitch. 1994. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 50:159-165.
37. Yuki, N., S. Sato, S. Tsuji, I. Hozumi, and T. Miyatake. 1993. An immunologie abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J. Neurol. Sci. 118:83-87.
38. Yuki, N., S. Sato, S. Tsuji, T. Ohsawa, and T. Miyatake. 1993. Frequent presence of anti-GQlb antibody in Fisher's syndrome. Neurology 43:414-417.
39. Yuki, N., T. Taki, F. Inagaki, T. Kasama, M. Takahashi, K. Saito, S. Handa, and T. Miyatake. 1993. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178: 1771-1775.
40. Yuki, N., T. Taki, M. Takahashi, K. Saito, H. Yoshino, T. Tai, S. Handa, and T. Miyatake. 1994. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36:791-793.
41. Yuki, N., Y. Ichihashi, and T. Taki. 1995. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J. Neuroimmunol. 60:161-164.
42. Yuki, N., M. Takahashi, Y. Tagawa, K. Kashiwase, K. Tadokoro, and K. Saito. 1997. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome. Ann. Neurol. 42:28-33.